U.S. Anorexiants Market: Insights and Forecast to 2030
The U.S. market is expanding steadily, supported by awareness campaigns and pharmaceutical advancements. Valued at USD 217.8 million in 2022, it is projected to reach USD 298.07 million by 2030, achieving a compound annual growth rate (CAGR) of 4.0% from 2023 to 2030.
